BCL-2 Inhibition at Antiretroviral Therapy Start Shrinks Intact SIV Reservoir
Targeting the BCL-2 cell-survival pathway at the start of antiretroviral therapy reduced the pool of intact SIV proviruses in macaques, ...
Targeting the BCL-2 cell-survival pathway at the start of antiretroviral therapy reduced the pool of intact SIV proviruses in macaques, ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine